BCL9 and plasma cell myeloma: In multiple myeloma cells, re-expression of PCDH10 suppressed nuclear localization of β-catenin, activity of LEF/TCF, expression of the β-catenin transcriptional cofactor BCL9, and of AKT, whereas expression of GSK3β was increased [37].